Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and …

JM Simons, TJA van Nijnatten, CC van der Pol… - Annals of …, 2019 - journals.lww.com
Objective: The aim of this study was to perform a systematic review and meta-analysis to
assess the accuracy of different surgical axillary staging procedures compared with ALND …

Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer

SR Tee, LA Devane, D Evoy, J Rothwell… - Journal of British …, 2018 - academic.oup.com
Background Neoadjuvant chemotherapy for breast cancer has the potential to achieve a
pathological complete response in up to 40 per cent of patients, converting disease that was …

Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at …

HEH Chehade, H Headon, O El Tokhy… - The American Journal of …, 2016 - Elsevier
BACKGROUND The use of sentinel lymph node biopsy (SLNB) following neoadjuvant
chemotherapy (NAC) in patients presenting with clinically positive lymph nodes remains …

The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer

R Alvarado, M Yi, H Le-Petross, M Gilcrease… - Annals of surgical …, 2012 - Springer
Background Sentinel lymph node (SLN) dissection has been investigated after neoadjuvant
chemotherapy and has shown mixed results. Our objective was to evaluate SLN dissection …

[HTML][HTML] Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial …

S Cao, X Liu, J Cui, X Liu, J Zhong, Z Yang, D Sun… - The Breast, 2021 - Elsevier
Purpose Neoadjuvant chemotherapy (NACT) is increasingly adopted in the therapy of breast
cancer (BC) patients with positive axillary nodes (cN+), but the reliability and feasibility of …

Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis

JF Fu, HL Chen, J Yang, CH Yi, S Zheng - PloS one, 2014 - journals.plos.org
Sentinel lymph node biopsy (SLNB) has replaced conventional axillary lymph node
dissection (ALND) in axillary node-negative breast cancer patients. However, the use of …

Assessment of sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer in two subgroups: Initially node negative and node positive converted to …

A Shirzadi, H Mahmoodzadeh… - Journal of Research in …, 2019 - journals.lww.com
Background: Neoadjuvant chemotherapy (NAC) is increasingly used to treat patients with
breast cancer, but the reliability of sentinel lymph node biopsy (SLNB) following …

Patterns of care in the administration of neo‐adjuvant chemotherapy for breast cancer. A population‐based study

G Vugts, AJG Maaskant‐Braat… - The Breast …, 2016 - Wiley Online Library
Neo‐adjuvant chemotherapy (NAC) is used to facilitate radical surgery for initially
irresectable or locally advanced breast cancer. The indication for NAC has been extended to …

Safety of neoadjuvant chemotherapy for the treatment of breast cancer

SH Ahmed - Expert Opinion on Drug Safety, 2019 - Taylor & Francis
Introduction: Preoperative systemic therapy (PST) including neoadjuvant chemotherapy
(NAC) in breast cancer (BC) is used nowadays on a large scale especially in aggressive BC …

The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic …

JC Vázquez, A Piñero, FJ de Castro, A Lluch… - Clinical and …, 2023 - Springer
Purpose To conduct a systematic review to analyse the performance of the sentinel lymph-
node biopsy (SLNB) in women with node-positive breast cancer at diagnosis and node …